Thomas Charles Heineman

Chief Medical Officer at Oncolytics Biotech · 1 reported transaction in 1 company · latest trade Feb 12, 2026

Their record

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −34.9%, S&P 500 +13.6% over the same days.


Oncolytics BiotechONCY	Bought $10K · 12,132 shares	Feb 12, 2026

Feb 12, 2026 · ONCY

$10K

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Medical Officer at Oncolytics Biotech · 1 reported transaction in 1 company · latest trade Feb 12, 2026

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −34.9%, S&P 500 +13.6% over the same days.


Oncolytics BiotechONCY	Bought $10K · 12,132 shares	Feb 12, 2026

Feb 12, 2026 · ONCY

$10K

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.